How much did Bayer achieve in EBIT for the current year?
In the current year, Bayer has achieved an EBIT of 5.86 B EUR.
Bayer EBIT 2024
Bayer EBIT
5.86 B EUR
Ticker
BAYN.DE
ISIN
DE000BAY0017
WKN
BAY001
In 2024, Bayer's EBIT was 5.86 B EUR, a -30.48% increase from the 8.42 B EUR EBIT recorded in the previous year.
The Bayer EBIT history
| YEAR | EBIT (undefined EUR) |
|---|---|
| 2029e | - |
| 2028e | 7.33 |
| 2027e | 6.74 |
| 2026e | 6.75 |
| 2025e | 6.22 |
| 2024e | 5.86 |
| 2023 | 8.42 |
| 2022 | 7.98 |
| 2021 | 6.88 |
| 2020 | -0.88 |
| 2019 | 4.66 |
| 2018 | -0.15 |
| 2017 | 5.99 |
| 2016 | 5.84 |
| 2015 | 6.64 |
| 2014 | 5.55 |
| 2013 | 4.97 |
| 2012 | 3.91 |
| 2011 | 3.97 |
| 2010 | 2.89 |
| 2009 | 3.77 |
| 2008 | 3.87 |
| 2007 | 3.84 |
| 2006 | 2.76 |
| 2005 | 2.81 |
| 2004 | 1.81 |
Bayer Revenue, EBIT, Net Income DE000BAY0017 · BAY001
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Bayer, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bayer from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bayer’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Bayer. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Bayer’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Bayer’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bayer’s growth potential.
Bayer Revenue, EBIT and net profit per share
| Date | Bayer Revenue | Bayer EBIT | Bayer Net Income |
|---|---|---|---|
| 2029e | 52.65 B undefined | 0 undefined | 6.23 B undefined |
| 2028e | 52.13 B undefined | 7.33 B undefined | 6.19 B undefined |
| 2027e | 50.47 B undefined | 6.74 B undefined | 5.89 B undefined |
| 2026e | 49.31 B undefined | 6.75 B undefined | 5.54 B undefined |
| 2025e | 48.62 B undefined | 6.22 B undefined | 5.33 B undefined |
| 2024e | 47.88 B undefined | 5.86 B undefined | 5.11 B undefined |
| 2023 | 47.64 B undefined | 8.42 B undefined | -2.94 B undefined |
| 2022 | 50.74 B undefined | 7.98 B undefined | 4.15 B undefined |
| 2021 | 44.08 B undefined | 6.88 B undefined | 1 B undefined |
| 2020 | 41.4 B undefined | -878 M undefined | -10.5 B undefined |
| 2019 | 43.55 B undefined | 4.66 B undefined | 4.09 B undefined |
| 2018 | 36.74 B undefined | -150 M undefined | 1.7 B undefined |
| 2017 | 35.02 B undefined | 5.99 B undefined | 7.34 B undefined |
| 2016 | 34.94 B undefined | 5.84 B undefined | 4.53 B undefined |
| 2015 | 46.09 B undefined | 6.64 B undefined | 4.11 B undefined |
| 2014 | 41.34 B undefined | 5.55 B undefined | 3.43 B undefined |
| 2013 | 40.16 B undefined | 4.97 B undefined | 3.19 B undefined |
| 2012 | 39.76 B undefined | 3.91 B undefined | 2.45 B undefined |
| 2011 | 36.53 B undefined | 3.97 B undefined | 2.47 B undefined |
| 2010 | 35.09 B undefined | 2.89 B undefined | 1.3 B undefined |
| 2009 | 31.17 B undefined | 3.77 B undefined | 1.36 B undefined |
| 2008 | 32.92 B undefined | 3.87 B undefined | 1.72 B undefined |
| 2007 | 32.39 B undefined | 3.84 B undefined | 4.71 B undefined |
| 2006 | 28.96 B undefined | 2.76 B undefined | 1.68 B undefined |
| 2005 | 27.38 B undefined | 2.81 B undefined | 1.6 B undefined |
| 2004 | 29.76 B undefined | 1.81 B undefined | 603 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 29.76 B EUR | 1.81 B EUR | 603 M EUR |
| 2005 | 27.38 B EUR | 2.81 B EUR | 1.6 B EUR |
| 2006 | 28.96 B EUR | 2.76 B EUR | 1.68 B EUR |
| 2007 | 32.39 B EUR | 3.84 B EUR | 4.71 B EUR |
| 2008 | 32.92 B EUR | 3.87 B EUR | 1.72 B EUR |
| 2009 | 31.17 B EUR | 3.77 B EUR | 1.36 B EUR |
| 2010 | 35.09 B EUR | 2.89 B EUR | 1.3 B EUR |
| 2011 | 36.53 B EUR | 3.97 B EUR | 2.47 B EUR |
| 2012 | 39.76 B EUR | 3.91 B EUR | 2.45 B EUR |
| 2013 | 40.16 B EUR | 4.97 B EUR | 3.19 B EUR |
| 2014 | 41.34 B EUR | 5.55 B EUR | 3.43 B EUR |
| 2015 | 46.09 B EUR | 6.64 B EUR | 4.11 B EUR |
| 2016 | 34.94 B EUR | 5.84 B EUR | 4.53 B EUR |
| 2017 | 35.02 B EUR | 5.99 B EUR | 7.34 B EUR |
| 2018 | 36.74 B EUR | -150 M EUR | 1.7 B EUR |
| 2019 | 43.55 B EUR | 4.66 B EUR | 4.09 B EUR |
| 2020 | 41.4 B EUR | -878 M EUR | -10.5 B EUR |
| 2021 | 44.08 B EUR | 6.88 B EUR | 1 B EUR |
| 2022 | 50.74 B EUR | 7.98 B EUR | 4.15 B EUR |
| 2023 | 47.64 B EUR | 8.42 B EUR | -2.94 B EUR |
| 2024e | 47.88 B EUR | 5.86 B EUR | 5.11 B EUR |
| 2025e | 48.62 B EUR | 6.22 B EUR | 5.33 B EUR |
| 2026e | 49.31 B EUR | 6.75 B EUR | 5.54 B EUR |
| 2027e | 50.47 B EUR | 6.74 B EUR | 5.89 B EUR |
| 2028e | 52.13 B EUR | 7.33 B EUR | 6.19 B EUR |
| 2029e | 52.65 B EUR | 0 EUR | 6.23 B EUR |
Bayer stock margins DE000BAY0017 · BAY001
The Bayer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bayer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bayer.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Bayer's sales revenue. A higher gross margin percentage indicates that the Bayer retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Bayer's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Bayer's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bayer's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bayer. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bayer's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Bayer Margin History
| Bayer Gross margin | Bayer Profit margin | Bayer EBIT margin | Bayer Profit margin |
|---|---|---|---|
| 2029e | 58.54 % | 0 % | 11.83 % |
| 2028e | 58.54 % | 14.06 % | 11.88 % |
| 2027e | 58.54 % | 13.36 % | 11.67 % |
| 2026e | 58.54 % | 13.68 % | 11.24 % |
| 2025e | 58.54 % | 12.79 % | 10.97 % |
| 2024e | 58.54 % | 12.23 % | 10.66 % |
| 2023 | 58.54 % | 17.68 % | -6.17 % |
| 2022 | 60.84 % | 15.73 % | 8.18 % |
| 2021 | 61.85 % | 15.61 % | 2.27 % |
| 2020 | 53.77 % | -2.12 % | -25.35 % |
| 2019 | 59.55 % | 10.7 % | 9.39 % |
| 2018 | 58.14 % | -0.41 % | 4.61 % |
| 2017 | 67.49 % | 17.12 % | 20.95 % |
| 2016 | 66.36 % | 16.7 % | 12.97 % |
| 2015 | 54.35 % | 14.41 % | 8.92 % |
| 2014 | 51.84 % | 13.42 % | 8.29 % |
| 2013 | 51.82 % | 12.39 % | 7.94 % |
| 2012 | 52.06 % | 9.84 % | 6.15 % |
| 2011 | 50.79 % | 10.86 % | 6.76 % |
| 2010 | 51.26 % | 8.23 % | 3.71 % |
| 2009 | 51.44 % | 12.1 % | 4.36 % |
| 2008 | 50.01 % | 11.77 % | 5.22 % |
| 2007 | 49.51 % | 11.84 % | 14.55 % |
| 2006 | 47.25 % | 9.54 % | 5.81 % |
| 2005 | 45.12 % | 10.27 % | 5.83 % |
| 2004 | 41.59 % | 6.08 % | 2.03 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 41.59 % | 6.08 % | 2.03 % |
| 2005 | 45.12 % | 10.27 % | 5.83 % |
| 2006 | 47.25 % | 9.54 % | 5.81 % |
| 2007 | 49.51 % | 11.84 % | 14.55 % |
| 2008 | 50.01 % | 11.77 % | 5.22 % |
| 2009 | 51.44 % | 12.1 % | 4.36 % |
| 2010 | 51.26 % | 8.23 % | 3.71 % |
| 2011 | 50.79 % | 10.86 % | 6.76 % |
| 2012 | 52.06 % | 9.84 % | 6.15 % |
| 2013 | 51.82 % | 12.39 % | 7.94 % |
| 2014 | 51.84 % | 13.42 % | 8.29 % |
| 2015 | 54.35 % | 14.41 % | 8.92 % |
| 2016 | 66.36 % | 16.7 % | 12.97 % |
| 2017 | 67.49 % | 17.12 % | 20.95 % |
| 2018 | 58.14 % | -0.41 % | 4.61 % |
| 2019 | 59.55 % | 10.7 % | 9.39 % |
| 2020 | 53.77 % | -2.12 % | -25.35 % |
| 2021 | 61.85 % | 15.61 % | 2.27 % |
| 2022 | 60.84 % | 15.73 % | 8.18 % |
| 2023 | 58.54 % | 17.68 % | -6.17 % |
| 2024e | 58.54 % | 12.23 % | 10.66 % |
| 2025e | 58.54 % | 12.79 % | 10.97 % |
| 2026e | 58.54 % | 13.68 % | 11.24 % |
| 2027e | 58.54 % | 13.36 % | 11.67 % |
| 2028e | 58.54 % | 14.06 % | 11.88 % |
| 2029e | 58.54 % | 0 % | 11.83 % |
Bayer Aktienanalyse
What does Bayer do?
Bayer AG is a German company that was founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal. The company started out as a manufacturer of dyes, but over time it has evolved into a leading global agrochemical, health, and life science company. Bayer's business model is based on the goal of finding innovative solutions to the societal challenges of the future. This includes promoting agriculture and health, as well as sustainability and the preservation of natural resources. Bayer specializes in three business areas: Pharmaceuticals, Consumer Health, and Crop Science. In the Pharmaceuticals division, Bayer develops and markets innovative drugs for a variety of diseases. The company focuses on research and development in key therapy areas such as cardiology, oncology, hematology, neurology, and immunology. Well-known and successful brands from Bayer in the Pharmaceuticals sector include Xarelto, Kogenate, Stivarga, Eylea, and Nexavar. In the Consumer Health division, Bayer develops and distributes products for consumer health and well-being. This includes self-medication products, dietary supplements, contact lens care products, and animal health products. Well-known brands from Bayer Consumer Health include Aspirin, Bepanthen, Berocca, Coppertone, and Advantage. In the Crop Science division, Bayer develops and markets products and solutions for agriculture. This includes crop protection products, seeds, plant breeding, and digital farming. The goal is to help farmers worldwide operate sustainably and productively to meet the growing demand for food. Well-known brands from Bayer Crop Science include Roundup, Decis, Diflubenzuron, and Dekalb. Bayer is known for its innovative power and has made many inventions and discoveries throughout its history. It was one of the first companies to develop synthetic dyes, and in 1897, it was also the first company in Germany to manufacture Aspirin. Since then, Bayer has made numerous groundbreaking discoveries and is now at the forefront of the pharmaceutical and agrochemical industry. Bayer is headquartered in Leverkusen and operates in over 90 countries worldwide. The company employs over 100,000 people and had a turnover of around 41 billion euros in 2020. The company is also committed to reducing its ecological footprint in line with its business goals and strives to improve sustainability in its value chain. Bayer ist eines der beliebtesten Unternehmen auf Eulerpool.com.Bayer revenue by segment
41 % Pharmaceuticals
13 % Consumer Health
1 % All Other Segments
45 % Crop Science
EBIT Details
Analyzing Bayer's EBIT
Bayer's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Bayer's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Bayer's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Bayer’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Bayer stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Bayer.
How has the EBIT of Bayer developed in recent years?
The EBIT of Bayer has increased by -30.476% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Bayer?
The EBIT of Bayer is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Bayer pay?
Over the past 12 months, Bayer paid a dividend of 2.4 EUR . This corresponds to a dividend yield of about 12.31 %. For the coming 12 months, Bayer is expected to pay a dividend of 2.43 EUR.
What is the dividend yield of Bayer?
The current dividend yield of Bayer is 12.31 %.
When does Bayer pay dividends?
Bayer pays a quarterly dividend. This is distributed in the months of May, June, June, May.
How secure is the dividend of Bayer?
Bayer paid dividends every year for the past 26 years.
What is the dividend of Bayer?
For the upcoming 12 months, dividends amounting to 2.43 EUR are expected. This corresponds to a dividend yield of 12.45 %.
In which sector is Bayer located?
Bayer is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bayer kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bayer from 5/2/2024 amounting to 0.11 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.
When did Bayer pay the last dividend?
The last dividend was paid out on 5/2/2024.
What was the dividend of Bayer in the year 2023?
In the year 2023, Bayer distributed 2 EUR as dividends.
In which currency does Bayer pay out the dividend?
The dividends of Bayer are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Bayer stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank
Andere Kennzahlen von Bayer
Our stock analysis for Bayer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
